Edwin J Wagena

Summary

Affiliation: Maastricht University
Country: The Netherlands

Publications

  1. ncbi request reprint Should nortriptyline be used as a first-line aid to help smokers quit? Results from a systematic review and meta-analysis
    E J Wagena
    Department of General Practice, Maastricht University, Maastricht, The Netherlands
    Addiction 100:317-26. 2005
  2. ncbi request reprint Chronic bronchitis, cigarette smoking, and the subsequent onset of depression and anxiety: results from a prospective population-based cohort study
    Edwin J Wagena
    Pulmonary Rehabilitation Centre Hornerheide, Haelen, Horn, The Netherlands
    Psychosom Med 67:656-60. 2005
  3. pmc Do drug firms hoodwink medical journals? Or is something wrong with the contribution and integrity of declared authors?
    E J Wagena
    Maastricht University, Care and Public Health Research Institute Caphri, Department of General Practice, Maastricht, The Netherlands
    J Med Ethics 31:307. 2005
  4. pmc The scandal of unfair behaviour of senior faculty
    E J Wagena
    Pulmonary Rehabilitation Centre Hornerheide, PO Box 4080, 6080 AB Haelen, The Netherlands
    J Med Ethics 31:308. 2005
  5. ncbi request reprint Risk of depression and anxiety in employees with chronic bronchitis: the modifying effect of cigarette smoking
    Edwin J Wagena
    Department of General Practice, Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands
    Psychosom Med 66:729-34. 2004
  6. doi request reprint The cost-effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients
    Constant P van Schayck
    Department of General Practice, Care and Public Health Research Institute Caphri, Maastricht University, Maastricht, The Netherlands
    Addiction 104:2110-7. 2009
  7. ncbi request reprint Smoking cessation practices of Dutch general practitioners, cardiologists, and lung physicians
    Daniel Kotz
    Department of General Practice, Care and Public Health Research Institute, Maastricht University, P O Box 616, 6200 MD Maastricht, The Netherlands
    Respir Med 101:568-73. 2007
  8. ncbi request reprint Psychological distress and depressed mood in employees with asthma, chronic bronchitis or emphysema: a population-based observational study on prevalence and the relationship with smoking cigarettes
    Edwin J Wagena
    Department of General Practice, Care and Public Health Research Institute Caphri, Maastricht University, The Netherlands
    Eur J Epidemiol 19:147-53. 2004
  9. doi request reprint Genetic variants in the serotonin transporter influence the efficacy of bupropion and nortriptyline in smoking cessation
    Marieke Quaak
    Department of Toxicology, Nutrition and Toxicology Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands
    Addiction 107:178-87. 2012
  10. doi request reprint The immunogenicity and safety of a nicotine vaccine in smokers and nonsmokers: results of a randomized, placebo-controlled phase 1/2 trial
    Edwin J Wagena
    Department of General Practice, Care and Public Health Research Institute Caphri, Maastricht University, Maastricht, The Netherlands
    Nicotine Tob Res 10:213-8. 2008

Detail Information

Publications17

  1. ncbi request reprint Should nortriptyline be used as a first-line aid to help smokers quit? Results from a systematic review and meta-analysis
    E J Wagena
    Department of General Practice, Maastricht University, Maastricht, The Netherlands
    Addiction 100:317-26. 2005
    ..The objective of this paper is to evaluate the efficacy of nortriptyline for smoking cessation compared to placebo and bupropion sustained release...
  2. ncbi request reprint Chronic bronchitis, cigarette smoking, and the subsequent onset of depression and anxiety: results from a prospective population-based cohort study
    Edwin J Wagena
    Pulmonary Rehabilitation Centre Hornerheide, Haelen, Horn, The Netherlands
    Psychosom Med 67:656-60. 2005
    ....
  3. pmc Do drug firms hoodwink medical journals? Or is something wrong with the contribution and integrity of declared authors?
    E J Wagena
    Maastricht University, Care and Public Health Research Institute Caphri, Department of General Practice, Maastricht, The Netherlands
    J Med Ethics 31:307. 2005
  4. pmc The scandal of unfair behaviour of senior faculty
    E J Wagena
    Pulmonary Rehabilitation Centre Hornerheide, PO Box 4080, 6080 AB Haelen, The Netherlands
    J Med Ethics 31:308. 2005
  5. ncbi request reprint Risk of depression and anxiety in employees with chronic bronchitis: the modifying effect of cigarette smoking
    Edwin J Wagena
    Department of General Practice, Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands
    Psychosom Med 66:729-34. 2004
    ..Furthermore, we tested whether these associations are different in people without any respiratory complaints and those with asthma...
  6. doi request reprint The cost-effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients
    Constant P van Schayck
    Department of General Practice, Care and Public Health Research Institute Caphri, Maastricht University, Maastricht, The Netherlands
    Addiction 104:2110-7. 2009
    ..We assessed which of both drugs was most effective and cost-effective in stopping smoking after 1 year compared with placebo among smokers at risk or with existing chronic obstructive pulmonary disease (COPD)...
  7. ncbi request reprint Smoking cessation practices of Dutch general practitioners, cardiologists, and lung physicians
    Daniel Kotz
    Department of General Practice, Care and Public Health Research Institute, Maastricht University, P O Box 616, 6200 MD Maastricht, The Netherlands
    Respir Med 101:568-73. 2007
    ..To assess and compare the smoking cessation practices and smoking behavior of Dutch general practitioners (GPs), cardiologists, and lung physicians...
  8. ncbi request reprint Psychological distress and depressed mood in employees with asthma, chronic bronchitis or emphysema: a population-based observational study on prevalence and the relationship with smoking cigarettes
    Edwin J Wagena
    Department of General Practice, Care and Public Health Research Institute Caphri, Maastricht University, The Netherlands
    Eur J Epidemiol 19:147-53. 2004
    ..Above all, we wanted to examine the influence of smoking status on the relationship between chronic disease and psychological distress/depressed mood...
  9. doi request reprint Genetic variants in the serotonin transporter influence the efficacy of bupropion and nortriptyline in smoking cessation
    Marieke Quaak
    Department of Toxicology, Nutrition and Toxicology Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands
    Addiction 107:178-87. 2012
    ..We investigated whether variants in the serotonin transporter gene (SLC6A4) influence smoking cessation rates using antidepressant therapy (i.e. bupropion and nortriptyline)...
  10. doi request reprint The immunogenicity and safety of a nicotine vaccine in smokers and nonsmokers: results of a randomized, placebo-controlled phase 1/2 trial
    Edwin J Wagena
    Department of General Practice, Care and Public Health Research Institute Caphri, Maastricht University, Maastricht, The Netherlands
    Nicotine Tob Res 10:213-8. 2008
    ..These observations provide evidence in humans that the vaccine we used may represent a feasible strategy for evoking type-specific antibodies against nicotine...
  11. ncbi request reprint Encouraging smokers to quit: the cost effectiveness of reimbursing the costs of smoking cessation treatment
    Janneke Kaper
    Department of General Practice, Care and Public Health Research Institute Caphri, Maastricht University, Maastricht, The Netherlands
    Pharmacoeconomics 24:453-64. 2006
    ..Results of a randomised trial suggested that reimbursing the costs of smoking cessation treatment (SCT) may lead to an increased use of SCT and an increased number of quitters versus no reimbursement...
  12. ncbi request reprint Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease
    Edwin J Wagena
    Research Institute for Extramural and Transmural Health Care ExTra, Maastricht University, Maastricht, The Netherlands
    Drug Saf 26:381-403. 2003
    ..We therefore recommend using a holistic approach in which the possible coexistence of multiple problems (which are known to affect the success of smoking cessation strategies) is integrated...
  13. ncbi request reprint Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease
    E J Wagena
    Department of General Practice, Maastricht University, The Netherlands
    Arch Intern Med 165:2286-92. 2005
    ..No clinical trial has studied the efficacy of bupropion hydrochloride and nortriptyline hydrochloride for smoking cessation in this patient population, to our knowledge...
  14. ncbi request reprint A randomized controlled trial to assess the effects of reimbursing the costs of smoking cessation therapy on sustained abstinence
    J Kaper
    Department of General Practice, Care and Public Health Research Institute Caphri, Maastricht University, Maastricht, The Netherlands
    Addiction 101:1656-61. 2006
    ..For 6 months, participants in the intervention group could apply for reimbursement and received information regarding the reimbursed SCT. Participants in the control group received no reimbursement or information...
  15. ncbi request reprint Reimbursement for smoking cessation treatment may double the abstinence rate: results of a randomized trial
    J Kaper
    Department of General Practice, Care and Public Health Research Institute Caphri, Maastricht University, 3200 MD Maastricht, The Netherlands
    Addiction 100:1012-20. 2005
    ..To increase the number of successful quitters, we assessed whether financial reimbursement for SCT would encourage the use of SCT and would as a result increase the 6-month point abstinence rate...
  16. ncbi request reprint The efficacy of smoking cessation strategies in people with chronic obstructive pulmonary disease: results from a systematic review
    E J Wagena
    Care and Public Health Research Institute, Department of General Practice, Maastricht University, Maastricht, The Netherlands
    Respir Med 98:805-15. 2004
    ..Present evidence suggests that the most effective intervention for prolonged smoking cessation in patients with COPD is the combination of nicotine replacement therapy, coupled with an intensive, prolonged relapse prevention programme...
  17. ncbi request reprint Management of patients with COPD
    Edwin J Wagena
    Lancet 364:2015-6. 2004